2024-10-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
19.6% |
0% |
2024-10-18 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
11.4% |
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
20.69% |
3.96% |
2024-08-29 |
The percentage of cash held in the portfolio is:
79.31%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
APLS |
Sell
All
|
-5.21% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
19.38% |
-2.65% |
2024-08-22 |
PODD
Insulet Corporation
|
Buy |
20.14% |
1.11% |
2024-08-29 |
The percentage of cash held in the portfolio is:
60.48%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
19.01% |
-4.2% |
2024-08-22 |
NEOG
Neogen Corporation
|
Buy |
19.42% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
19.86% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
41.71%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
19.5% |
-0.64% |
2024-08-22 |
NEOG
Neogen Corporation
|
Buy |
19.63% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
60.88%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
19.6% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-14 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
5.88% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RMD
ResMed Inc.
|
Buy |
19.66% |
2.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
80.34%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
-1.15% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
20.92% |
-1% |
2024-07-18 |
RMD
ResMed Inc.
|
Buy |
19.27% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
59.81%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
20.48% |
-0.19% |
2024-07-18 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
20.07% |
1.6% |
2024-07-26 |
The percentage of cash held in the portfolio is:
59.45%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ATRC |
Sell
All
|
-12.65% |
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ATRC
AtriCure, Inc.
|
Buy |
18.95% |
-7% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
20.2% |
-0.84% |
2024-07-18 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
19.62% |
0% |
2024-07-26 |
The percentage of cash held in the portfolio is:
41.24%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ATRC
AtriCure, Inc.
|
Buy |
19.18% |
-5.18% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
20.41% |
0.92% |
2024-07-18 |
The percentage of cash held in the portfolio is:
60.41%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SAGE |
Sell
All
|
-11.55% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SAGE
Sage Therapeutics, Inc.
|
Buy |
20.19% |
3.54% |
2024-07-12 |
ATRC
AtriCure, Inc.
|
Buy |
19.32% |
-0.91% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
19.5% |
0% |
2024-07-18 |
The percentage of cash held in the portfolio is:
40.99%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SAGE
Sage Therapeutics, Inc.
|
Buy |
20.17% |
3.62% |
2024-07-12 |
ATRC
AtriCure, Inc.
|
Buy |
19.46% |
0% |
2024-07-17 |
The percentage of cash held in the portfolio is:
60.37%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SAGE
Sage Therapeutics, Inc.
|
Buy |
19.6% |
0% |
2024-07-12 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-09 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ACAD |
Sell
All
|
2.77% |
Assets Rebalanced
None
2024-07-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
19.24% |
-1.83% |
2024-06-25 |
The percentage of cash held in the portfolio is:
80.76%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Sell
All
|
1.87% |
Assets Rebalanced
None
2024-06-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
19.32% |
-1.76% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
19.67% |
0% |
2024-06-26 |
The percentage of cash held in the portfolio is:
61.01%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
19.6% |
0% |
2024-06-25 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-30 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BCRX |
Sell
All
|
-3.3% |
Assets Rebalanced
None
2024-05-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
19.92% |
-0.47% |
2024-05-16 |
The percentage of cash held in the portfolio is:
80.08%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
-7.87% |
Assets Rebalanced
None
2024-05-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
19.45% |
-1.26% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
19.89% |
1.02% |
2024-05-17 |
The percentage of cash held in the portfolio is:
60.67%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OMCL |
Sell
All
|
1.03% |
Assets Rebalanced
None
2024-05-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OMCL
Omnicell, Inc.
|
Buy |
19.81% |
5.08% |
2024-05-06 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
19.81% |
1.73% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
19.46% |
0% |
2024-05-17 |
The percentage of cash held in the portfolio is:
40.92%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OMCL
Omnicell, Inc.
|
Buy |
18.97% |
-0.86% |
2024-05-06 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
19.76% |
0% |
2024-05-16 |
The percentage of cash held in the portfolio is:
61.27%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OMCL
Omnicell, Inc.
|
Buy |
19.1% |
-0.03% |
2024-05-06 |
The percentage of cash held in the portfolio is:
80.9%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PTCT |
Sell
All
|
12.88% |
Assets Rebalanced
None
2024-05-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
21.98% |
15.54% |
2024-04-29 |
OMCL
Omnicell, Inc.
|
Buy |
19.01% |
0% |
2024-05-06 |
The percentage of cash held in the portfolio is:
59.02%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
19.6% |
0% |
2024-04-29 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-11 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TNDM |
Sell
All
|
-2.07% |
Assets Rebalanced
None
2024-03-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
19.6% |
0% |
2024-03-28 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-21 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BAX |
Sell
All
|
-2.7% |
Assets Rebalanced
None